# Aeterna Medical Solutions SL: Observational study in Hypercholesterolemia, Cardiovascular Risk (100000 participants)

**Score:** 55/100

| Field | Value |
|---|---|
| Sponsor | Aeterna Medical Solutions SL |
| Sponsor type | Academic and hospital |
| Study | Long-Term Cardiovascular Impact of ArmoLIPID Cholesterol Plus: An In Silico Study Using Digital Twins |
| NCT ID | NCT07892092 |
| Phase | Observational |
| Status | completed |
| Conditions | Hypercholesterolemia; Cardiovascular Risk |
| Target enrollment | 100000 |
| Site countries | Spain |
| Posted | 2026-10-23 |
| Planned start | 2026-09-01 |
| Event | Newly registered study |
| Event date | 2026-10-23 |

## Why this score
- Posted in the last two weeks.
- 100000 participants planned.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07892092). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.